APA (7th ed.) Citation

U, C., T, M., G, G., MP, G., & K, C. (2026). Selective pulmonary vasorelaxant effects of an N2,N4-diaminoquinazoline PDE5 inhibitor involving endothelial signaling and ion channel modulation. European journal of pharmacology, 1030, 179154. https://doi.org/10.1016/j.ejphar.2026.179154

Chicago Style (17th ed.) Citation

U, Chatturong, Meebangsue T, Guntur G, Gleeson MP, and Chootip K. "Selective Pulmonary Vasorelaxant Effects of an N2,N4-diaminoquinazoline PDE5 Inhibitor Involving Endothelial Signaling and Ion Channel Modulation." European Journal of Pharmacology 1030 (2026): 179154. https://doi.org/10.1016/j.ejphar.2026.179154.

MLA (9th ed.) Citation

U, Chatturong, et al. "Selective Pulmonary Vasorelaxant Effects of an N2,N4-diaminoquinazoline PDE5 Inhibitor Involving Endothelial Signaling and Ion Channel Modulation." European Journal of Pharmacology, vol. 1030, 2026, p. 179154, https://doi.org/10.1016/j.ejphar.2026.179154.